Home > Insider Trading > Filing (0001104659-24-097867)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1974640	Apogee Therapeutics Inc.	APGE	Biological Products, (No Disgnostic Substances) (2836)	934958665

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1983476	Carl Dambkowski	C/O Apogee Therapeutics, Inc. 221 Crescent St., Bldg. 17, Ste. 102B Waltham MA 02453	Chief Medical Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2024-09-04	5,878	$47.49	281,580	No	4	S	Direct
Common Stock	Disposition	2024-09-04	787	$48.06	280,793	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct

Footnotes

This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on September 27, 2023.
The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $46.79 to $47.77, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range.
The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $47.80 to $48.42, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.